The Journal of surgical research

Nicotinamide Mononucleotide Reduces Lung Injury Caused by LPS Through Anti-Inflammatory, Antioxidant, and Cell-Protection Effects

Updated

Abstract

Nicotinamide mononucleotide (NMN) significantly improved lung health in a mouse model of acute lung injury induced by lipopolysaccharide.

  • NMN treatment reduced pathological damage and cell death in lung tissue compared to the LPS group.
  • Levels of inflammatory cytokines TNF-α, IL-1β, and IL-6 in bronchoalveolar lavage fluid were decreased with NMN administration.
  • The total cell count and neutrophil count in bronchoalveolar lavage fluid were lower in the NMN-treated group.
  • NMN lowered the dry-to-wet ratio and malondialdehyde (MDA) content, indicators of lung injury.
  • Phosphorylation levels of p38 MAPK and p65 NF-κB were reduced with NMN treatment, suggesting decreased inflammation.
  • Superoxide dismutase (SOD) activity was increased following NMN treatment, indicating enhanced antioxidative response.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free